{
"id":"mk19_bb_id_s36",
"subspecialtyId":"id",
"title":"Hospital-Acquired and Ventilator-Associated Pneumonia",
"jsonContent":{
"type":"section",
"id":"mk19_bb_id_s36",
"title":{
"__html":"Hospital-Acquired and Ventilator-Associated Pneumonia"
},
"titleNode":{
"type":"section-title",
"hlId":"210eb2",
"children":[
"Hospital-Acquired and Ventilator-Associated Pneumonia"
]
},
"children":[
{
"type":"section",
"id":"mk19_bb_id_s36_1",
"title":{
"__html":"Prevention"
},
"titleNode":{
"type":"section-title",
"hlId":"c53b76",
"children":[
"Prevention"
]
},
"children":[
{
"type":"p",
"hlId":"1c9f1c",
"children":[
{
"type":"abbreviation",
"title":"hospital-acquired pneumonia",
"children":[
"HAP"
]
},
" is defined as pneumonia that occurs ≥48 hours after admission. ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"ventilator-associated pneumonia",
"children":[
"VAP"
]
},
","
]
},
" a subset of HAP, is defined as occurring >48 hours after endotracheal intubation."
]
},
{
"type":"p",
"hlId":"d460bd",
"children":[
"Procedures to reduce VAP include:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"344190",
"children":[
"minimizing sedation"
]
},
" ",
{
"type":"list-item",
"hlId":"6d087b",
"children":[
"following daily weaning protocols for timely extubation"
]
},
" ",
{
"type":"list-item",
"hlId":"217b73",
"children":[
"keeping the head of the bed elevated >30 degrees"
]
},
" ",
{
"type":"list-item",
"hlId":"1e2d72",
"children":[
"avoiding nasal intubation and nasogastric tubes"
]
},
" ",
{
"type":"list-item",
"hlId":"7ec158",
"children":[
"using chlorhexidine mouth rinse and subglottic suction catheters"
]
},
" ",
{
"type":"list-item",
"hlId":"ae6ffc",
"children":[
"facilitating early mobility"
]
},
" "
]
}
]
},
{
"type":"section",
"id":"mk19_bb_id_s36_2",
"title":{
"__html":"Diagnosis"
},
"titleNode":{
"type":"section-title",
"hlId":"523223",
"children":[
"Diagnosis"
]
},
"children":[
{
"type":"p",
"hlId":"819a7b",
"children":[
"The diagnosis of HAP is based on a new or progressive radiographic infiltrate plus clinical signs of pneumonia (fever, purulent sputum, leukocytosis, hypoxemia)."
]
},
{
"type":"p",
"hlId":"262dc9",
"children":[
"Obtain specimen for culture."
]
}
]
},
{
"type":"section",
"id":"mk19_bb_id_s36_3",
"title":{
"__html":"Treatment"
},
"titleNode":{
"type":"section-title",
"hlId":"4c4ac0",
"children":[
"Treatment"
]
},
"children":[
{
"type":"p",
"hlId":"5e87d5",
"children":[
"The main risk factor for ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"methicillin-resistant Staphylococcus aureus",
"children":[
"MRSA"
]
},
","
]
},
" antibiotic-resistant ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Pseudomonas"
]
},
", or other antibiotic-resistant pathogens is intravenous antibiotic use within the past 90 days."
]
},
{
"type":"p",
"hlId":"290a19",
"children":[
"Additional risk factors for antibiotic-resistant pathogens associated with VAP are:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"aa6002",
"children":[
"septic shock at the time of VAP"
]
},
" ",
{
"type":"list-item",
"hlId":"1ec0a0",
"children":[
{
"type":"abbreviation",
"title":"acute respiratory distress syndrome",
"children":[
"ARDS"
]
},
" preceding VAP"
]
},
" ",
{
"type":"list-item",
"hlId":"300c3e",
"children":[
"5 or more days of hospitalization before VAP"
]
},
" ",
{
"type":"list-item",
"hlId":"92da08",
"children":[
"kidney replacement therapy before VAP"
]
},
" "
]
},
{
"type":"p",
"hlId":"e82f77",
"children":[
"Initiate empiric antibiotic therapy for HAP or VAP pending culture results."
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"47642b",
"children":[
"Cover ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"S. aureus"
]
},
" with vancomycin or linezolid if MRSA resistance risk factors are present or MRSA prevalence is >10% or unknown."
]
},
" ",
{
"type":"list-item",
"hlId":"59a4be",
"children":[
"Cover ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Pseudomonas"
]
},
" with two antipseudomonal agents of different classes (e.g., piperacillin-tazobactam plus gentamicin) if resistance risk factors are present, prevalence is >10%, or bronchiectasis or cystic fibrosis is present."
]
},
" "
]
},
{
"type":"p",
"hlId":"a8eee0",
"children":[
"Choose monotherapy with cefepime, piperacillin-tazobactam, or levofloxacin for patients with no resistance risk factors; choose one agent to treat ",
{
"type":"abbreviation",
"title":"methicillin-sensitive Staphylococcus aureus",
"children":[
"MSSA"
]
},
" (e.g., nafcillin) in patients with no risk factors for MRSA."
]
},
{
"type":"p",
"hlId":"44f3f0",
"children":[
"Narrow the empiric therapy based on culture results."
]
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"1fa0a5",
"children":[
"Do not delay empiric antibiotic therapy to perform diagnostic studies."
]
},
" "
]
}
]
},
{
"type":"section",
"id":"mk19_bb_id_s36_4",
"title":{
"__html":"Test Yourself"
},
"titleNode":{
"type":"section-title",
"hlId":"7866cc",
"children":[
"Test Yourself"
]
},
"children":[
{
"type":"p",
"hlId":"3557ba",
"class":"test",
"children":[
"A 78-year-old woman was admitted from home for treatment of a hip fracture. Four days after admission, she develops a temperature of 38.3 °C (100.9 °F) and a cough. A chest x-ray shows a new left lower lobe infiltrate."
]
},
{
"type":"p",
"hlId":"27bccc",
"class":"test_answer",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Answer:"
]
},
" ",
"For diagnosis, choose HAP; for treatment, select cefepime, piperacillin-tazobactam, or levofloxacin and nafcillin."
]
}
]
}
]
},
"tablesContent":{
}
}